SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,338,100 | -56.9% | 1,668,518 | -1.4% | 0.00% | -55.6% |
| Q2 2023 | $79,585,770 | +37.9% | 1,692,594 | +23.1% | 0.01% | +28.6% |
| Q1 2023 | $57,708,000 | +106996.7% | 1,375,318 | -2.7% | 0.01% | 0.0% |
| Q4 2022 | $53,884 | -99.9% | 1,412,831 | -7.6% | 0.01% | -22.2% |
| Q3 2022 | $59,864,000 | +19.5% | 1,528,747 | -1.5% | 0.01% | +28.6% |
| Q2 2022 | $50,112,000 | -6.2% | 1,551,467 | -3.9% | 0.01% | +16.7% |
| Q1 2022 | $53,412,000 | -19.6% | 1,613,650 | +3.3% | 0.01% | -25.0% |
| Q4 2021 | $66,433,000 | +28.7% | 1,561,622 | +34.1% | 0.01% | +33.3% |
| Q3 2021 | $51,605,000 | -20.4% | 1,164,621 | +2.0% | 0.01% | -25.0% |
| Q2 2021 | $64,862,000 | -23.3% | 1,141,726 | +1.1% | 0.01% | -27.3% |
| Q1 2021 | $84,529,000 | -35.1% | 1,129,316 | -25.0% | 0.01% | -42.1% |
| Q4 2020 | $130,291,000 | +42.1% | 1,506,075 | -2.0% | 0.02% | +26.7% |
| Q3 2020 | $91,658,000 | +58.6% | 1,536,076 | +10.5% | 0.02% | +36.4% |
| Q2 2020 | $57,809,000 | +42.9% | 1,390,309 | -1.3% | 0.01% | +22.2% |
| Q1 2020 | $40,447,000 | -59.6% | 1,408,362 | +1.5% | 0.01% | -52.6% |
| Q4 2019 | $100,194,000 | -22.6% | 1,387,944 | +50.5% | 0.02% | -26.9% |
| Q3 2019 | $129,399,000 | -21.6% | 922,373 | +0.9% | 0.03% | -18.8% |
| Q2 2019 | $164,958,000 | +8.9% | 914,201 | -4.0% | 0.03% | +3.2% |
| Q1 2019 | $151,426,000 | +66.1% | 952,068 | +0.1% | 0.03% | +47.6% |
| Q4 2018 | $91,149,000 | -31.1% | 951,542 | +1.7% | 0.02% | -16.0% |
| Q3 2018 | $132,217,000 | -9.5% | 936,058 | +0.3% | 0.02% | -16.7% |
| Q2 2018 | $146,035,000 | +25.6% | 932,958 | +29.3% | 0.03% | +20.0% |
| Q1 2018 | $116,242,000 | -10.4% | 721,686 | -8.3% | 0.02% | -7.4% |
| Q4 2017 | $129,678,000 | +146.1% | 787,307 | -6.1% | 0.03% | +125.0% |
| Q3 2017 | $52,700,000 | -19.2% | 838,094 | +2.4% | 0.01% | -20.0% |
| Q2 2017 | $65,199,000 | +10.0% | 818,671 | -1.9% | 0.02% | +7.1% |
| Q1 2017 | $59,294,000 | +16.3% | 834,295 | -16.5% | 0.01% | +16.7% |
| Q4 2016 | $50,999,000 | -8.2% | 998,787 | -17.2% | 0.01% | -14.3% |
| Q3 2016 | $55,562,000 | +71.4% | 1,206,544 | +12.1% | 0.01% | +75.0% |
| Q2 2016 | $32,423,000 | -1.4% | 1,076,113 | +4.9% | 0.01% | 0.0% |
| Q1 2016 | $32,893,000 | -41.6% | 1,025,990 | +6.2% | 0.01% | -42.9% |
| Q4 2015 | $56,341,000 | +48.0% | 966,408 | +7.4% | 0.01% | +40.0% |
| Q3 2015 | $38,065,000 | -35.6% | 899,460 | +11.1% | 0.01% | -28.6% |
| Q2 2015 | $59,102,000 | +48.0% | 809,638 | +1.9% | 0.01% | +55.6% |
| Q1 2015 | $39,923,000 | +512.6% | 794,792 | +346.3% | 0.01% | +800.0% |
| Q4 2014 | $6,517,000 | +252.1% | 178,071 | +203.0% | 0.00% | – |
| Q3 2014 | $1,851,000 | – | 58,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |